True North Therapeutics, Inc.
Records under this name other than patents True North Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to True North Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,512,233 | ANTI-COMPLEMENT C1S ANTIBODIES AND METHODS OF INHIBITING COMPLEMENT C1s ACTIVITY Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,562,092 | METHODS OF INHIBITING COMPLEMENT C4 ACTIVATION WITH ANTI-COMPLEMENT C1s ANTIBODIES Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,562,106 | ANTI-COMPLEMENT C1s ANTIBODIES AND METHODS OF INHIBITING COMPLEMENT C1s ACTIVITY Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,457,745 | ANTI-COMPLEMENT C1s ANTIBODIES Formerly held In force · Low confidence | In force | Low confidence | |
| US 12,215,169 | Anti-Complement C1S Antibodies and Uses Thereof Formerly held In force · Low confidence | In force | Low confidence | |
| US 8,945,562 | Anti-Complement C1S Antibodies Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,074,003 | METHODS OF INHIBITING ACTIVATION OF COMPLEMENT COMPONENT C4 WITH ANTI-C1s ANTIBODIES Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,074,004 | Methods of Inhibiting Activation of Complement Component C4 with ANTI-C1S Antibodies Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,206,259 | Methods of Inhibiting Complement C4 Activation with Anti-Complement C1S Antibodies Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,450,382 | ANTI-COMPLEMENT C1s ANTIBODIES Formerly held In force · Medium confidence | In force | Medium confidence |